Unresectable Malignant Solid Neoplasm Recruiting Phase 1 Trials for Capecitabine (DB01101)

IndicationStatusPhase
DBCOND0110416 (Unresectable Malignant Solid Neoplasm)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05803382
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable CancersTreatment